(Q44092232)

29 November 2017

Increased gray matter volume in lithium-treated bipolar disorder patients (English)

1 reference

29 November 2017

1 reference

7

Matcheri S Keshavan

1 reference

29 November 2017

6

David J Kupfer

1 reference

29 November 2017

3

Paolo Brambilla

1 reference

29 November 2017

2

Mark Nicoletti

1 reference

29 November 2017

1

Roberto B Sassi

1 reference

29 November 2017

4

Alan G Mallinger

1 reference

29 November 2017

5

Ellen Frank

1 reference

29 November 2017

8

Jair C Soares

1 reference

PubMed ID

12165422

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

29 November 2017

1 reference

29 November 2017

329

1 reference

29 November 2017

243-245

1 reference

29 November 2017

2

1 reference

Differential effects of age on brain gray matter in bipolar patients and healthy individuals.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900615-8

7 January 2021

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900615-8

7 January 2021

Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900615-8

7 January 2021

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900615-8

7 January 2021

Lithium-induced increase in human brain grey matter

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900615-8

7 January 2021

10.1016/S0304-3940(02)00615-8

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12165422